BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 29403798)

  • 1. Development and validation of a stability indicating RP-HPLC method for the determination of Rufinamide.
    Sai Pavan Kumar B; Mathrusri Annapurna M; Pavani S
    J Pharm Anal; 2013 Feb; 3(1):66-70. PubMed ID: 29403798
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Development and validation of a stability-indicating RP-HPLC method for estimation of atazanavir sulfate in bulk.
    Dey S; Subhasis Patro S; Suresh Babu N; Murthy PN; Panda SK
    J Pharm Anal; 2017 Apr; 7(2):134-140. PubMed ID: 29404029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development and validation of the stability-indicating LC-UV method for the determination of Cefditoren pivoxil.
    Annapurna MM; Goutam SVS; Anusha S; Srinivas L
    J Pharm Anal; 2012 Dec; 2(6):466-469. PubMed ID: 29403785
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stability-indicating liquid chromatographic method for the determination of Letrozole in pharmaceutical formulations.
    Annapurna MM; Mohapatro C; Narendra A
    J Pharm Anal; 2012 Aug; 2(4):298-305. PubMed ID: 29403757
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and validation of a stability-indicating RP-HPLC method for the determination of febuxostat (a xanthine oxidase inhibitor).
    Mukthinuthalapati MA; Bandaru SP; Bukkapatnam V; Mohapatro C
    J Chromatogr Sci; 2013; 51(10):931-8. PubMed ID: 23204011
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Stability-Indicating RP-HPLC Method for Determination of Tamsulosin HCL in Pharmaceutical Dosage Form.
    Kumar GS; Kumar BS
    J Basic Clin Pharm; 2012 Mar; 3(2):255-60. PubMed ID: 24826033
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Validation of assay indicating method development of meloxicam in bulk and some of its tablet dosage forms by RP-HPLC.
    Sahoo NK; Sahu M; Rao PS; Rani NS; Devi JI; Ghosh G
    Springerplus; 2014; 3():95. PubMed ID: 24711980
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stress degradation studies and development of a validated stability-indicating-assay-method for determination of diacerein in presence of degradation products.
    Hamrapurkar P; Patil P; Desai M; Phale M; Pawar S
    Pharm Methods; 2011 Jan; 2(1):30-5. PubMed ID: 23781427
    [TBL] [Abstract][Full Text] [Related]  

  • 9. New stability chiral RP-HPLC method for degradation products determination in midodrine hydrochloride.
    Byran G; Ashwini J; Lakshmanan K; Rajagopal K; Subramanian G; Meyyanathan SN
    Drug Dev Ind Pharm; 2021 Jul; 47(7):1072-1078. PubMed ID: 33818229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development of a Forced Degradation Profile of Alosetron by Single Mode Reversed-Phase HPLC, LC-MS, and its Validation.
    Karthik Y; Babu B; Meyyanathan SN
    Sci Pharm; 2015; 83(2):311-20. PubMed ID: 26839817
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Stability indicating RP-HPLC method for methylcobalamin determination in different dosage forms: Application to photodegradation kinetics and pH rate profiling.
    Amer MM; Kamal AH; Hammad SF; Habib AA
    J Sep Sci; 2022 Aug; 45(15):2877-2886. PubMed ID: 35670513
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetics study of metaxalone degradation under hydrolytic, oxidative and thermal stress conditions using stability-indicating HPLC method.
    Marothu VK; Dash RN; Vemula S; Donkena S; Devi R; Gorrepati M
    J Pharm Anal; 2012 Dec; 2(6):431-436. PubMed ID: 29403778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. HPLC-PDA identification and resolution of rufinamide forced degradation impurities: A congregated chemometric expedite optimization coupled with factorials and desirability.
    Ganorkar SB; Chaudhari SR; Bobade PS; Pawar SH; Shirkhedkar AA
    Biomed Chromatogr; 2022 May; 36(5):e5345. PubMed ID: 35062045
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of Rufinamide in the Presence of 1-[(2,6-Difluorophenyl)Methyl]-1H-1,2,3-Triazole-4 Carboxylic Acid Using RP-HPLC and Derivative Ratio Methods as Stability Indicating Assays to Be Applied on Dosage Form.
    Hassib ST; Hashem HMA; Mahrouse MA; Mostafa EA
    J AOAC Int; 2020 Sep; 103(5):1215-1222. PubMed ID: 33241408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Determination of stress-induced degradation products of cetirizine dihydrochloride by a stability-indicating RP-HPLC method.
    Flórez Borges P; Pérez Lozano P; García Montoya E; Miñarro M; Ticó JR; Jo E; Suñe Negre JM
    Daru; 2014 Dec; 22(1):82. PubMed ID: 25487685
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stability indicating liquid chromatographic method for the simultaneous determination of rosuvastatin and ezetimibe in pharmaceutical formulations.
    Mukthinuthalapati MA; Bukkapatnam V; Bandaru SP
    Adv Pharm Bull; 2014 Dec; 4(4):405-11. PubMed ID: 25436199
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability-Indicating RP-HPLC Method for Simultaneous Estimation of Enrofloxacin and Its Degradation Products in Tablet Dosage Forms.
    Chakravarthy VA; Sailaja BB; Kumar AP
    J Anal Methods Chem; 2015; 2015():735145. PubMed ID: 25705547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Development and Validation of a Stability-Indicating HPLC Method for the Simultaneous Determination of Florfenicol and Flunixin Meglumine Combination in an Injectable Solution.
    Batrawi N; Naseef H; Al-Rimawi F
    J Anal Methods Chem; 2017; 2017():1529280. PubMed ID: 28781907
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stability-indicating RP-LC method for determination of azilsartan medoxomil and chlorthalidone in pharmaceutical dosage forms: application to degradation kinetics.
    Ebeid WM; Elkady EF; El-Zaher AA; El-Bagary RI; Patonay G
    Anal Bioanal Chem; 2014 Oct; 406(26):6701-12. PubMed ID: 25190009
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and validation of stability-indicating HPLC method for determination of cefpirome sulfate.
    Zalewski P; Skibiński R; Cielecka-Piontek J; Bednarek-Rajewska K
    Acta Pol Pharm; 2014; 71(5):731-6. PubMed ID: 25362801
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.